Status:
TERMINATED
Musculoskeletal Effects of Isotretinoin During Acne Treatment in Pediatric Population
Lead Sponsor:
University of Wisconsin, Madison
Conditions:
Acne
Eligibility:
All Genders
12-21 years
Brief Summary
This is a prospective study, that will follow participants over their course of treatment on Isotretinoin. All patients who are prescribed Isotretinoin for their acne treatment are registered in iPLED...
Eligibility Criteria
Inclusion
- Registered in I-Pledge and has not started the Isotretinoin medication
- Females and males ages 12-21 years old
- Able to undergo 3 MRI scan
Exclusion
- Participants taking additional vitamin A, D or Calcium supplements
- Previous musculoskeletal injuries (from incidental trauma, sports related injury or motorvehicle accidents, etc)
- Clinical diagnosis of psoriasis, rheumatoid arthritis and/or Reiter's disease
- relocation within the next 6 months
- participation on a research study involving drug medication within the past 30 days
Key Trial Info
Start Date :
July 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2013
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT00964119
Start Date
July 1 2008
End Date
August 1 2013
Last Update
February 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Wisconsin, Madison
Madison, Wisconsin, United States, 53715